[go: up one dir, main page]

ES8701778A1 - Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos - Google Patents

Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos

Info

Publication number
ES8701778A1
ES8701778A1 ES551625A ES551625A ES8701778A1 ES 8701778 A1 ES8701778 A1 ES 8701778A1 ES 551625 A ES551625 A ES 551625A ES 551625 A ES551625 A ES 551625A ES 8701778 A1 ES8701778 A1 ES 8701778A1
Authority
ES
Spain
Prior art keywords
representing
alkyl
carbon atoms
group
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551625A
Other languages
English (en)
Other versions
ES551625A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853504421 external-priority patent/DE3504421A1/de
Priority claimed from DE19853527517 external-priority patent/DE3527517A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES8701778A1 publication Critical patent/ES8701778A1/es
Publication of ES551625A0 publication Critical patent/ES551625A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE 13-ALQUIL-11B-FENIL-GONANOS, DE FORMULA GENERAL (I), DONDE A Y B SON O, CH2 O UN DOBLE ENLACE; X ES O O FNOH; R1 ES UN ALQUILO SATURADO O INSATURADO, LINEAL O RAMIFICADO C1-C8; R2 ES UN METILO O ETILO EN A O B; SI R2 ESTA EN A, R3/R4 TIENEN DIFERENTES SIGNIFICADOS Y SI ESTA EN B TIENEN OTROS; R9, R10, R11 Y R12 REPRESENTAN EN CADA CASO H, OH, ALQUILO, ALCOXI O ACILOXI, EN CADA CASO C1-C4, O UN HALOGENO Y EL SUSTITUYENTE DEL 11B-FENILO ESTA EN POSICION 3 O 4. SE OBTIENEN A PARTIR DE PRECURSORES POR HIDROXILACION MICROBIOLOGICA CON STR. TOYOCAENSIS, Y/O STR. PLATENSIS Y/O NIGROSPORA SPHAERICA Y/O NEUROSPORA CRASA Y LOS COMPUESTOS HIDROXILADOS OBTENIDOS, DE FORMULA (I), SEGUN LOS CASOS SE EPIMERIZAN, ESTERIFICAN-ETERIFICAN, HALOGENAN O ALCOHILAN. LOS COMPUESTOS SON ANTAGONISTAS COMPETITIVOS DE LA PROGESTERONA Y SE USAN COMO ANTIGESTAGENOS, REGULADORES DE MENSTRUACION Y ANTIGLUCORTICOIDES.
ES551625A 1985-02-07 1986-02-04 Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos Expired ES8701778A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853504421 DE3504421A1 (de) 1985-02-07 1985-02-07 Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19853527517 DE3527517A1 (de) 1985-07-29 1985-07-29 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
ES8701778A1 true ES8701778A1 (es) 1986-12-16
ES551625A0 ES551625A0 (es) 1986-12-16

Family

ID=25829248

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551625A Expired ES8701778A1 (es) 1985-02-07 1986-02-04 Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos

Country Status (16)

Country Link
US (1) US5089635A (es)
EP (1) EP0190759B1 (es)
CN (1) CN1033753C (es)
AU (1) AU580843B2 (es)
CA (1) CA1310630C (es)
DE (1) DE3665307D1 (es)
DK (1) DK161709C (es)
ES (1) ES8701778A1 (es)
FI (1) FI85377C (es)
GR (1) GR860342B (es)
HU (1) HU194904B (es)
IE (1) IE58149B1 (es)
IL (1) IL77762A (es)
NO (1) NO171994C (es)
NZ (1) NZ214998A (es)
PT (1) PT81969B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
ES2045082T3 (es) * 1987-04-24 1994-01-16 Akzo Nv Un metodo para la preparacion de nuevos derivados 11-arilestrano y 11-arilpregnano.
AU625450B2 (en) * 1987-07-16 1992-07-09 Schering Aktiengesellschaft Berlin Und Bergkamen 11beta-phenyl-4,9,15-estratrienes, their manufacture, and pharmaceutical preparations containing them
DE3723788A1 (de) * 1987-07-16 1989-01-26 Schering Ag 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
EP0321010B1 (en) * 1987-12-12 1993-02-03 Akzo N.V. New 11-arylsteroid compounds
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
DE69034035T2 (de) * 1989-07-07 2004-01-22 Endorecherche Inc., Ste-Foy Methode zur behandlung androgenbedingter krankheiten
WO1991001958A2 (de) * 1989-08-04 1991-02-21 Schering Aktiengesellschaft Berlin Und Bergkamen 11β-ARYL-GONA-4,9-DIEN-3-ONE
DE4042007A1 (de) * 1990-12-22 1992-06-25 Schering Ag 6,7-modifizierte-11(beta)-aryl-4-estrene
ES2112268T3 (es) * 1990-08-14 1998-04-01 Hoechst Marion Roussel Inc Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena carbonada que comprende una funcion amida, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
FR2688004A1 (fr) * 1992-02-27 1993-09-03 Roussel Uclaf Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.
CA2136304A1 (en) * 1992-05-21 1993-11-25 Fernand Labrie Inhibitors of testosterone 5.alpha.-reductase activity
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
AU710139B2 (en) 1996-05-01 1999-09-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The 21-substituted progesterone derivatives as new antiprogestational agents
IL122740A (en) * 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
ES2762243T3 (es) 2010-05-26 2020-05-22 Corcept Therapeutics Inc Tratamiento de distrofia muscular
AU2016226451B2 (en) 2015-03-02 2019-12-19 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
CN107530339B (zh) 2015-03-30 2021-03-16 科赛普特治疗学股份有限公司 糖皮质激素受体拮抗剂联合糖皮质激素用于治疗肾上腺功能不全
MX383318B (es) 2015-08-13 2025-03-13 Corcept Therapeutics Inc Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina.
KR102197526B1 (ko) 2016-01-19 2020-12-31 코어셉트 쎄라퓨틱스 인코포레이티드 이소성 쿠싱 증후군의 감별 진단
MX2019011543A (es) 2017-03-31 2019-12-16 Corcept Therapeutics Inc Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical.
ES3043682T3 (en) 2017-06-20 2025-11-25 Corcept Therapeutics Inc Treatment of neuroepithelial tumors using selective glucocorticoid receptor modulators
US20240269280A1 (en) 2020-12-18 2024-08-15 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3231827A1 (de) * 1982-08-24 1984-03-01 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-17(alpha)-alkinyl-17ss-hydroxy-4,9(10)- estradien-3-on-derivate, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions

Also Published As

Publication number Publication date
GR860342B (en) 1986-06-03
FI860559L (fi) 1986-08-08
IE860334L (en) 1986-08-07
HU194904B (en) 1988-03-28
DK56086D0 (da) 1986-02-05
FI860559A0 (fi) 1986-02-07
HUT40453A (en) 1986-12-28
AU580843B2 (en) 1989-02-02
IL77762A (en) 1992-08-18
NZ214998A (en) 1989-06-28
DK161709B (da) 1991-08-05
NO171994B (no) 1993-02-15
FI85377C (fi) 1992-04-10
DK56086A (da) 1986-08-08
AU5291386A (en) 1986-08-14
CN86100994A (zh) 1986-10-08
EP0190759B1 (de) 1989-08-30
US5089635A (en) 1992-02-18
NO171994C (no) 1993-05-26
CN1033753C (zh) 1997-01-08
FI85377B (fi) 1991-12-31
DE3665307D1 (en) 1989-10-05
EP0190759A2 (de) 1986-08-13
NO860425L (no) 1986-08-08
IE58149B1 (en) 1993-07-14
PT81969A (de) 1986-03-01
PT81969B (pt) 1988-03-03
EP0190759A3 (en) 1986-11-20
ES551625A0 (es) 1986-12-16
DK161709C (da) 1992-01-13
CA1310630C (en) 1992-11-24

Similar Documents

Publication Publication Date Title
ES8701778A1 (es) Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos
IE791437L (en) Alkyl derivatives of c-076 compounds
EP0323409A3 (en) Polyolefin compositions stabilized with long chain n,n-dialkylhydroxylamines
IL130182A0 (en) Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
ES8203388A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
ES8401496A1 (es) Cianoesteroides.
FR2685332B1 (es)
UA42674C2 (uk) Спосіб одержання похідних 3-кето-4-азастероїду та проміжні сполуки для його здійснення
ES469201A1 (es) Un metodo de preparacion de compuestos de alcoxisilano con doble agrupamiento.
ES269967A1 (es) Un procedimiento para la preparaciën de pirazolonas sustituidas
YU49500B (sh) Novi postupak izomerizacije 10-metil radikala derivata eritromicina
ES8105976A1 (es) Procedimiento para la preparacion de acilureas
GB1367819A (en) Tetrahydrodibenzopyrans
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
ES472877A1 (es) Procedimiento para preparar derivados de 25-alquilcolesterol
US4138549A (en) Inter-phenylene-PG pyrrolinylamides
ES440723A1 (es) Procedimiento para la produccion de nuevos compuestos orga- nicos.
GB1240087A (en) N(6)-alkyl-adenosine derivatives
ES8500910A1 (es) Un procedimiento para la preparacion de 6-(fenil sustituido)-3(2h)-piridazinonas.
ES8305372A1 (es) "procedimiento para la fabricacion de derivados de la tetrahidros -5,6,7,7a 4h-tieno (3,2-c)piridinona-2".
ES8502700A1 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
IL63747A (en) Cardenolide bis-digitoxosides,processes for the preparation thereof and pharmaceutical compositions containing them
ES421511A1 (es) Un procedimiento de preparacion de nuevos 2,2-dimetil-este-roides.
SE8004622L (sv) Acylaminobensoesyraderivat
ES471267A1 (es) Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041025